SCHEMBL25587161

SCHEMBL25587161

Cc1nc(C)nc(-c2c(F)cccc2F)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
LMNA P02545 1/20 0.38
ACHE P22303 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
NPY5R Q15761 1/20 0.36
TYK2 P29597 5/20 0.35
TTR P02766 1/20 0.35
PARP1 P09874 1/20 0.34
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE2A O00408 2/20 0.32
PDE10A Q9Y233 2/20 0.32
CSNK1D P48730 1/20 0.32
CSNK1E P49674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12655182 0.73 L3MBTL1 (0.41) L3MBTL1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL9566587 0.73 HRH4 (0.57) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL10203915 0.73 RAB9A (0.44) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL15890878 0.73 L3MBTL1 (0.41) L3MBTL1LMNASMN1; SMN2
SCHEMBL18812086 0.72 NPC1 (0.40) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL8372471 0.72 TTR (0.41) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL20110472 0.71 L3MBTL1 (0.50) L3MBTL1ACHESMN1; SMN2
SCHEMBL20928241 0.71 L3MBTL1 (0.50) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL19823579 0.71 L3MBTL1 (0.50) HRH4L3MBTL1NPC1RAB9ALMNA
SCHEMBL6503377 0.71 SMN1; SMN2 (0.43) HRH4NPC1RAB9ALMNATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11794180-B2 Tri-(adamantyl)phosphines and applications thereof THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2023-10-24 US disclosed
US-20230158480-A1 TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF UNIV PRINCETON (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11794180-B2 Tri-(adamantyl)phosphines and applications thereof PADI3, ADA, ENTPD3 HRH4 2032/4885L3MBTL1 4016/4885NPC1 4482/4885
US-20230158480-A1 TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF PADI3, ADA, ENTPD3 HRH4 2032/4885L3MBTL1 4016/4885NPC1 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.